Cargando…

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma

BRCA1/2 are breast cancer susceptibility genes that are involved in DNA repair and transcriptional control. They are dysregulated in breast cancer, making them attractive therapeutic targets. Here, we performed a systematic multiomics analysis to expound BRCA1/2 functions as prognostic biomarkers in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Tong Yi, Park, Kyoung Sik, Nam, Sang Eun, Yoo, Young Bum, Park, Won Seo, Yun, Ik Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998777/ https://www.ncbi.nlm.nih.gov/pubmed/35409110 http://dx.doi.org/10.3390/ijms23073754

Ejemplares similares

Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma
por: Nam, Sang Eun, et al.
Publicado: (2022)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach
por: Saindane, Madhuri, et al.
Publicado: (2020)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
por: Chen, Cheng, et al.
Publicado: (2020)

SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Feng, Dechao, et al.
Publicado: (2021)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
por: Park, Kyoung Sik, et al.
Publicado: (2021)

Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients()
por: Park, See-Hyoung, et al.
Publicado: (2015)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

Risk factors for poor prognosis in nosocomial infective endocarditis
por: Hwang, Ji-won, et al.
Publicado: (2018)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Peripapillary choroidal microvasculature dropout is associated with poor prognosis in optic neuritis
por: Lee, Jihei Sara, et al.
Publicado: (2023)

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
por: Go, Se-Il, et al.
Publicado: (2022)

Postthyroidectomy obesity in a Korean population: does the extent of surgery matter?
por: Park, Min-Young, et al.
Publicado: (2019)

PRDX4 overexpression is associated with poor prognosis in gastric cancer
por: Park, Sun Yi, et al.
Publicado: (2020)

Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers
por: Yan, Max, et al.
Publicado: (2012)

Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
por: Han, Hyunho, et al.
Publicado: (2022)

Loss of Human Leukocyte Antigen Class I Expression Is Associated with Poor Prognosis in Patients with Advanced Breast Cancer
por: Park, Hong Sik, et al.
Publicado: (2019)

Sialidase NEU1 May Serve as a Potential Biomarker of Proliferation, Migration and Prognosis in Melanoma
por: Peng, Qiu, et al.
Publicado: (2022)

Lactate as a Biomarker for Sepsis Prognosis?
por: Kang, Ha Eun, et al.
Publicado: (2016)

Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients
por: Heo, Jung Won, et al.
Publicado: (2020)

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
por: Zhou, Yi, et al.
Publicado: (2014)

Erratum: Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
por: Shin, Gi Won, et al.
Publicado: (2020)

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2
por: Hwang, Sang Mee, et al.
Publicado: (2018)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

Overexpression of FRAT1 protein is closely related to triple-negative breast cancer
por: Nam, Sang Eun, et al.
Publicado: (2022)

FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma
por: Jo, Joon-Hyung, et al.
Publicado: (2022)

APACHE II Score, Rather Than Cardiac Function, May Predict Poor Prognosis in Patients With Stress-Induced Cardiomyopathy
por: Joe, Byung-Hyun, et al.
Publicado: (2012)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines
por: Kim, Yun Gyoung, et al.
Publicado: (2019)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients
por: Lin, Rongbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_02oaf9tgmu8vd3dis1lhukmbnd